NeuroMetrix Announces Availability of Quell at Brookstone.com
NeuroMetrix, Inc. (Nasdaq:NURO) announced today that Quell® is now available at Brookstone.com.
"Brookstone is known for selling leading edge technology," said Shai N. Gozani, M.D., Ph.D., President and CEO of
NeuroMetrix. "We are pleased to be working with Brookstone to broaden the availability of our Quell proprietary, 100% drug free
technology for the relief of widespread chronic pain.”
Quell is FDA cleared and designed for millions of people suffering from chronic pain. The latest version of Quell gives users
the option to start, stop, and adjust therapy discreetly via their smartphone. It also enables advanced sleep tracking that
provides feedback on multiple dimensions of sleep including sleep duration, quality, body position, time out of bed, and repetitive
leg movements throughout the night. In addition to Brookstone.com, Quell is available at Target, select healthcare professionals
and retailers, and at www.quellrelief.com.
About Brookstone
Brookstone is a nationwide specialty retailer offering an assortment of consumer products that are functional in purpose,
distinctive in quality and design and not widely available from other retailers. In addition to their website, Brookstone operates
more than 200 retail stores throughout the United States and Puerto Rico, primarily in premium shopping malls, lifestyle centers
and the nation's busiest airports.
About NeuroMetrix
NeuroMetrix is an innovative health-care company that develops wearable medical technology and point-of-care tests that
help patients and physicians better manage chronic pain, nerve diseases, and sleep disorders. The company is located
in Waltham, Massachusetts and was founded as a spinoff from the Harvard-MIT Division of Health Sciences and
Technology in 1996. For more information, please visit www.NeuroMetrix.com.
NeuroMetrix, Inc.
Thomas T. Higgins, 781-314-2761
SVP and Chief Financial Officer
neurometrix.ir@neurometrix.com
View source version on businesswire.com: http://www.businesswire.com/news/home/20160516005341/en/